# Roivant Sciences Ltd.: Form 8-K/A, filed Mar 23, 2026

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: 8-K/A
- Filed: 2026-03-23
- Accepted by EDGAR: Mar 23, 2026, 08:44 ET
- Period: 2026-03-03
- Accession: 0001140361-26-010656
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/ef20068452_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000114036126010656/ef20068452_8ka.htm

Filed Mar 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-010656. Last ingested by Listed: Nov 3, 2026, 20:10 ET. No prices; not investment advice.